Search results
Why Bernie Sanders’ Ozempic crusade is misguided
Dallas Morning News· 1 day agoIt’s not surprising that Sanders, one of the most vociferous critics of the pharmaceutical industry in Congress, would take such a critical approach.
Syndax reports encouraging results from AML treatment trials By Investing.com
Investing.com· 5 days agoSyndax Pharmaceuticals (NASDAQ: NASDAQ:SNDX), a clinical stage biopharmaceutical company, has...
Congress Asset Management Co. MA Sells 1,209 Shares of Abbott Laboratories (NYSE:ABT)
ETF DAILY NEWS· 1 day agoCongress Asset Management Co. MA cut its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 14.9% during the 4th quarter, according to the company in its most ...
Cranbury Pharmaceuticals Receives FDA Approval for First Generic Version of Emflaza Oral Suspension
New Jersey Business Magazine· 6 days agoCranbury Pharmaceuticals, a wholly-owned subsidiary of Tris Pharma, today announced the U.S. Food...
Vertex says Casgevy benefit extends to nearly five years in sickle cell disease
Clinical Trials Arena via Yahoo Finance· 5 days agoVertex Pharmaceuticals has reported long-term data for its gene therapy Casgevy (exa-cel) in...
Nvidia, AbbVie, Vertex Pharmaceuticals And An Oil Giant: CNBC's 'Final Trades' - NVIDIA...
Benzinga· 2 days agoOn CNBC's Halftime Report, Bryn Talkington picked NVIDIA, Jim Lebenthal chose Vertex Pharmaceuticals...
Community pharmacists join the PBM ad frenzy
Politico· 2 days agoPCMA is...
Why are Mustang Bio shares (MBIO) up almost 500%? | Invezz Why are Mustang Bio shares (MBIO) up...
Invezz· 1 day agoThe pharmaceutical company has gone vertical in the past 24 hours, climbing 476.9% to go from $0.13...
Who Pays?
The Dispatch via Yahoo News· 1 day agoIt is an imbecilic idea, and there’s no particular reason to...Trump would seriously pursue it—given that he has rarely seriously pursued substantive...
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Short Interest Update
ETF DAILY NEWS· 3 days agoAcurx Pharmaceuticals, Inc. (NASDAQ:ACXP – Get Free Report) was the recipient of a large growth in short interest in May. As of May 31st, there was short interest totalling ...
